Serum Proteomics and Plasma Fibulin-3 in Differentiation of Mesothelioma From Asbestos-Exposed Controls and Patients With Other Pleural Diseases

No Thumbnail Available
Issue Date
2021
Our author(s)
Mukherjee, D
Department
Keywords
Language
English
Publisher
Elsevier
ISSN
1556-0864
1556-1380
eISSN
ISBN
Type
Article
Citation
Tsim, S., Kelly, C., Shaw, A., Hinsley, S., Clark, S., Evison, M., Holme, J., Cameron, E. J., Sharma, D., Wright, A., Grundy, S., Grieve, D., Ionescu, A., Breen, D. P., Paramasivam, E., Psallidas, I., Mukherjee, D., Chetty, M., Cox, G., Hart-Thomas, A., Naseer, R., Edwards, J., Daneshvar, C., Panchal, R., Munavvar, M., Ostroff, R., Alexander, L., Hall, H., Neilson, M., Miller, C., Mccormick, C., Thomson, F., Chalmers, A. J., Maskell, N. A. & Blyth, K. G. 2021. Serum Proteomics and Plasma Fibulin-3 in Differentiation of Mesothelioma From Asbestos-Exposed Controls and Patients With Other Pleural Diseases. Journal of Thoracic Oncology, 16, (10) 1705-1717.
Pubmed ID
URL
Description